Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
Clinical trial NCT01421017 · COMPLETED
Trial details
- NCT number
- NCT01421017
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-19
- Primary completion
- 2016-07-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.